https://www.selleckchem.com/pr....oducts/3-methyladeni
In dyspeptic patients with contributes to non-alcoholic fatty liver disease. However, little evidence available from Pakistan. The study aims to determine the frequency and risk factors of non-alcoholic fatty liver disease in dyspeptic patients with . This cross-sectional study was conducted between 22 November 2016 and 30 June 2018. Adults of age between 18 and 90 years who attended the out-patient department due to abdominal discomfort, pain, fullness, and bloating who underwent upper gastrointestinal tract endoscopy were enro
Like
Comment
Share
